SSH - WILMINGTON INC — History
CCN 082000 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
-2.4%
Revenue CAGR (3yr)
2.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $21M | $22M | $20M | -6.1% | -2.4% |
| Operating Expenses | $17M | $20M | $20M | -1.4% | +6.1% |
| Operating Margin | 17.5% | 7.4% | 2.7% | -63.2% | -60.6% |
| Net Income | $4M | $2M | $1M | -65.5% | -61.5% |
| Licensed Beds | 35 | 35 | 34 | -2.9% | -1.4% |
| Total Patient Days | 10,790 | 11,290 | 11,653 | +3.2% | +3.9% |
| Medicare Day % | 61% | 50% | 41% | -17.3% | -17.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -4.6% ($21M → $20M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-2.4%
This Hospital
+7.6%
State Avg
Latest Margin
2.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $20M | -4.7% |
| FY2024 (proj) | $19M | -12.1% |
| FY2025 (proj) | $19M | -19.5% |